{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:05:06Z","timestamp":1794535506200,"version":"4.9.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH084894"],"award-info":[{"award-number":["R01MH084894"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH111940"],"award-info":[{"award-number":["R01MH111940"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F31DA057818"],"award-info":[{"award-number":["F31DA057818"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA007027"],"award-info":[{"award-number":["T32DA007027"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA058089"],"award-info":[{"award-number":["R01DA058089"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA056187"],"award-info":[{"award-number":["R01DA056187"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30DA033934"],"award-info":[{"award-number":["P30DA033934"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA007027"],"award-info":[{"award-number":["T32DA007027"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30DA033934"],"award-info":[{"award-number":["P30DA033934"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA022537"],"award-info":[{"award-number":["R01AA022537"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM143940"],"award-info":[{"award-number":["R01GM143940"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R25GM089614"],"award-info":[{"award-number":["R25GM089614"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64887-w","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:41:43Z","timestamp":1763638903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid reward"],"prefix":"10.1038","volume":"16","author":[{"given":"Alaina M.","family":"Jaster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Hadlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0031-7377","authenticated-orcid":false,"given":"Belle","family":"Buzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4469-745X","authenticated-orcid":false,"given":"Jessica L.","family":"Maltman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6293-1052","authenticated-orcid":false,"given":"Gabriella M.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somdatta","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-4024","authenticated-orcid":false,"given":"Eda","family":"Koseli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6250-105X","authenticated-orcid":false,"given":"Abby M.","family":"Pondelick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ledesma-Corvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karah N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah R.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia L.","family":"Zylko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa R.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin L.","family":"Poklis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Halquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3812-9312","authenticated-orcid":false,"given":"Jennifer T.","family":"Wolstenholme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3118-9339","authenticated-orcid":false,"given":"Dana E.","family":"Selley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6819-8346","authenticated-orcid":false,"given":"Peter J.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0181-5888","authenticated-orcid":false,"given":"Chang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Imad","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3105-3204","authenticated-orcid":false,"given":"Javier","family":"Gonz\u00e1lez-Maeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"64887_CR1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jama.1996.03530350017014","volume":"275","author":"R Twycross","year":"1996","unstructured":"Twycross, R. & Lickiss, N. Pain control and the World Health Organization analgesic ladder. JAMA 275, 835 (1996).","journal-title":"JAMA"},{"key":"64887_CR2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1124\/pr.112.007138","volume":"65","author":"GW Pasternak","year":"2013","unstructured":"Pasternak, G. W. & Pan, Y. X. Mu opioids and their receptors: evolution of a concept. Pharm. Rev. 65, 1257\u20131317 (2013).","journal-title":"Pharm. Rev."},{"key":"64887_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMsr1706626","volume":"377","author":"ND Volkow","year":"2017","unstructured":"Volkow, N. D. & Collins, F. S. The Role of Science in Addressing the Opioid Crisis. N. Engl. J. Med 377, 391\u2013394 (2017).","journal-title":"N. Engl. J. Med"},{"key":"64887_CR4","doi-asserted-by":"crossref","unstructured":"Townsend, E. A., Negus, S. S. & Banks, M. L. Medications Development for Treatment of Opioid Use Disorder. Cold Spring Harb. perspect. med. 11, a039263 (2020).","DOI":"10.1101\/cshperspect.a039263"},{"key":"64887_CR5","doi-asserted-by":"crossref","unstructured":"Jalal, H. et al. Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science 361, eaau1184 (2018).","DOI":"10.1126\/science.aau1184"},{"key":"64887_CR6","doi-asserted-by":"publisher","first-page":"e2327488","DOI":"10.1001\/jamanetworkopen.2023.27488","volume":"6","author":"CM Jones","year":"2023","unstructured":"Jones, C. M. et al. Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021. JAMA Netw. Open 6, e2327488 (2023).","journal-title":"JAMA Netw. Open"},{"key":"64887_CR7","doi-asserted-by":"publisher","first-page":"173264","DOI":"10.1016\/j.pbb.2021.173264","volume":"210","author":"SS Negus","year":"2021","unstructured":"Negus, S. S. & Banks, M. L. Confronting the challenge of failed translation in medications development for substance use disorders. Pharm. Biochem Behav. 210, 173264 (2021).","journal-title":"Pharm. Biochem Behav."},{"key":"64887_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/7854_2017_478","volume":"36","author":"JF Lopez-Gimenez","year":"2018","unstructured":"Lopez-Gimenez, J. F. & Gonzalez-Maeso, J. Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways. Curr. Top. Behav. Neurosci. 36, 45\u201373 (2018).","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"64887_CR9","doi-asserted-by":"crossref","unstructured":"Jaster, A. M., de la Fuente Revenga, M. & Gonzalez-Maeso, J. Molecular targets of psychedelic-induced plasticity. J Neurochem (2021).","DOI":"10.1111\/jnc.15536"},{"key":"64887_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0269881114548296","volume":"28","author":"MW Johnson","year":"2014","unstructured":"Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P. & Griffiths, R. R. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J. Psychopharmacol. 28, 983\u2013992 (2014).","journal-title":"J. Psychopharmacol."},{"key":"64887_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0269881114565144","volume":"29","author":"MP Bogenschutz","year":"2015","unstructured":"Bogenschutz, M. P. et al. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J. Psychopharmacol. 29, 289\u2013299 (2015).","journal-title":"J. Psychopharmacol."},{"key":"64887_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/psymed.2023.0012","volume":"1","author":"CR Nicholas","year":"2023","unstructured":"Nicholas, C. R. et al. Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings. Psychedelic Med (N. Rochelle) 1, 253\u2013261 (2023).","journal-title":"Psychedelic Med (N. Rochelle)"},{"key":"64887_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1177\/0269881117691453","volume":"31","author":"VD Pisano","year":"2017","unstructured":"Pisano, V. D. et al. The association of psychedelic use and opioid use disorders among illicit users in the United States. J. Psychopharmacol. 31, 606\u2013613 (2017).","journal-title":"J. Psychopharmacol."},{"key":"64887_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08085-4","volume":"12","author":"G Jones","year":"2022","unstructured":"Jones, G., Ricard, J. A., Lipson, J. & Nock, M. K. Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample. Sci. Rep. 12, 4099 (2022).","journal-title":"Sci. Rep."},{"key":"64887_CR15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3389\/fpsyt.2019.00955","volume":"10","author":"A Garcia-Romeu","year":"2019","unstructured":"Garcia-Romeu, A. et al. Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey. Front Psychiatry 10, 955 (2019).","journal-title":"Front Psychiatry"},{"key":"64887_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","volume":"53","author":"J Gonzalez-Maeso","year":"2007","unstructured":"Gonzalez-Maeso, J. et al. Hallucinogens Recruit Specific Cortical 5-HT(2A) Receptor-Mediated Signaling Pathways to Affect Behavior. Neuron 53, 439\u2013452 (2007).","journal-title":"Neuron"},{"key":"64887_CR17","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","volume":"9","author":"FX Vollenweider","year":"1998","unstructured":"Vollenweider, F. X. et al. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9, 3897\u20133902 (1998).","journal-title":"Neuroreport"},{"key":"64887_CR18","doi-asserted-by":"crossref","unstructured":"Schmid, Y. et al. Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects. Biol Psychiatry (2015).","DOI":"10.1016\/j.biopsych.2014.11.015"},{"key":"64887_CR19","doi-asserted-by":"crossref","unstructured":"Shao, L. X. et al. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron 109, 2535\u20132544 (2021).","DOI":"10.1016\/j.neuron.2021.06.008"},{"key":"64887_CR20","doi-asserted-by":"crossref","unstructured":"Hesselgrave, N. et al. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. Proc. Natl. Acad. Sci. USA 118, e2022489118 (2021).","DOI":"10.1073\/pnas.2022489118"},{"key":"64887_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109836","volume":"37","author":"M de la Fuente Revenga","year":"2021","unstructured":"de la Fuente Revenga, M. et al. Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice. Cell Rep. 37, 109836 (2021).","journal-title":"Cell Rep."},{"key":"64887_CR22","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1126\/science.adf0435","volume":"379","author":"MV Vargas","year":"2023","unstructured":"Vargas, M. V. et al. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science 379, 700\u2013706 (2023).","journal-title":"Science"},{"key":"64887_CR23","doi-asserted-by":"crossref","unstructured":"Shao, L. X. et al. Psilocybin\u2019s lasting action requires pyramidal cell types and 5-HT(2A) receptors. Nature (2025).","DOI":"10.1038\/s41586-025-08813-6"},{"key":"64887_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1021\/acschemneuro.2c00718","volume":"14","author":"LP Cameron","year":"2023","unstructured":"Cameron, L. P. et al. 5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines. ACS Chem. Neurosci. 14, 351\u2013358 (2023).","journal-title":"ACS Chem. Neurosci."},{"key":"64887_CR25","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1038\/s41380-023-02274-x","volume":"28","author":"AM Jaster","year":"2023","unstructured":"Jaster, A. M. & Gonzalez-Maeso, J. Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics. Mol. Psychiatry 28, 3595\u20133612 (2023).","journal-title":"Mol. Psychiatry"},{"key":"64887_CR26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fphar.2016.00514","volume":"7","author":"G Pang","year":"2016","unstructured":"Pang, G. et al. Blockade of Serotonin 5-HT(2A) Receptors Suppresses Behavioral Sensitization and Naloxone-Precipitated Withdrawal Symptoms in Morphine-Treated Mice. Front Pharm. 7, 514 (2016).","journal-title":"Front Pharm."},{"key":"64887_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.108988","volume":"209","author":"S Sierra","year":"2022","unstructured":"Sierra, S. et al. Sex-specific role for serotonin 5-HT2A receptor in modulation of opioid-induced antinociception and reward in mice. Neuropharmacology 209, 108988 (2022).","journal-title":"Neuropharmacology"},{"key":"64887_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107933","volume":"167","author":"AL Halberstadt","year":"2020","unstructured":"Halberstadt, A. L. et al. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology 167, 107933 (2020).","journal-title":"Neuropharmacology"},{"key":"64887_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136836","volume":"788","author":"AM Jaster","year":"2022","unstructured":"Jaster, A. M. et al. Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL\/6J mice. Neurosci. Lett. 788, 136836 (2022).","journal-title":"Neurosci. Lett."},{"key":"64887_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1021\/cn300138m","volume":"4","author":"JB Hanks","year":"2013","unstructured":"Hanks, J. B. & Gonzalez-Maeso, J. Animal models of serotonergic psychedelics. ACS Chem. Neurosci. 4, 33\u201342 (2013).","journal-title":"ACS Chem. Neurosci."},{"key":"64887_CR31","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(20)30852-7","volume":"395","author":"AB Srivastava","year":"2020","unstructured":"Srivastava, A. B., Mariani, J. J. & Levin, F. R. New directions in the treatment of opioid withdrawal. Lancet 395, 1938\u20131948 (2020).","journal-title":"Lancet"},{"key":"64887_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2024.173795","volume":"242","author":"KM Contreras","year":"2024","unstructured":"Contreras, K. M. et al. Characterization and validation of a spontaneous acute and protracted oxycodone withdrawal model in male and female mice. Pharm. Biochem Behav. 242, 173795 (2024).","journal-title":"Pharm. Biochem Behav."},{"key":"64887_CR33","doi-asserted-by":"publisher","first-page":"109891","DOI":"10.1016\/j.neuropharm.2024.109891","volume":"248","author":"RH Cole","year":"2024","unstructured":"Cole, R. H., Moussawi, K. & Joffe, M. E. Opioid modulation of prefrontal cortex cells and circuits. Neuropharmacology 248, 109891 (2024).","journal-title":"Neuropharmacology"},{"key":"64887_CR34","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1073\/pnas.95.2.735","volume":"95","author":"RL Jakab","year":"1998","unstructured":"Jakab, R. L. & Goldman-Rakic, P. S. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc. Natl Acad. Sci. USA 95, 735\u2013740 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64887_CR35","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/1096-9861(20010122)429:4<571::AID-CNE5>3.0.CO;2-X","volume":"429","author":"JF Lopez-Gimenez","year":"2001","unstructured":"Lopez-Gimenez, J. F., Vilaro, M. T., Palacios, J. M. & Mengod, G. Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies. J. Comp. Neurol. 429, 571\u2013589 (2001).","journal-title":"J. Comp. Neurol."},{"key":"64887_CR36","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1523\/JNEUROSCI.23-08-03531.2003","volume":"23","author":"K McFarland","year":"2003","unstructured":"McFarland, K., Lapish, C. C. & Kalivas, P. W. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 23, 3531\u20133537 (2003).","journal-title":"J. Neurosci."},{"key":"64887_CR37","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41386-021-00955-1","volume":"46","author":"LY Zhang","year":"2021","unstructured":"Zhang, L. Y. et al. Restoring glutamate homeostasis in the nucleus accumbens via endocannabinoid-mimetic drug prevents relapse to cocaine seeking behavior in rats. Neuropsychopharmacology 46, 970\u2013981 (2021).","journal-title":"Neuropsychopharmacology"},{"key":"64887_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/humu.23677","volume":"40","author":"F McLachlan","year":"2019","unstructured":"McLachlan, F., Sires, A. M. & Abbott, C. M. The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders. Hum. Mutat. 40, 131\u2013141 (2019).","journal-title":"Hum. Mutat."},{"key":"64887_CR39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.biopsych.2016.09.015","volume":"81","author":"G Egervari","year":"2017","unstructured":"Egervari, G. et al. Striatal H3K27 acetylation linked to glutamatergic gene dysregulation in human heroin abusers holds promise as therapeutic target. Biol. Psychiatry 81, 585\u2013594 (2017).","journal-title":"Biol. Psychiatry"},{"key":"64887_CR40","doi-asserted-by":"publisher","first-page":"17454","DOI":"10.1523\/JNEUROSCI.1357-12.2012","volume":"32","author":"H Sun","year":"2012","unstructured":"Sun, H. et al. Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens. J. Neurosci. 32, 17454\u201317464 (2012).","journal-title":"J. Neurosci."},{"key":"64887_CR41","doi-asserted-by":"publisher","first-page":"9076","DOI":"10.1523\/JNEUROSCI.4194-13.2014","volume":"34","author":"Z Zhang","year":"2014","unstructured":"Zhang, Z. et al. MeCP2 repression of G9a in regulation of pain and morphine reward. J. Neurosci. 34, 9076\u20139087 (2014).","journal-title":"J. Neurosci."},{"key":"64887_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s42003-022-03035-2","volume":"5","author":"LB Naler","year":"2022","unstructured":"Naler, L. B. et al. Epigenomic and transcriptomic analyses reveal differences between low-grade inflammation and severe exhaustion in LPS-challenged murine monocytes. Commun. Biol. 5, 102 (2022).","journal-title":"Commun. Biol."},{"key":"64887_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ymeth.2012.05.001","volume":"58","author":"JM Belton","year":"2012","unstructured":"Belton, J. M. et al. Hi-C: a comprehensive technique to capture the conformation of genomes. Methods 58, 268\u2013276 (2012).","journal-title":"Methods"},{"key":"64887_CR44","doi-asserted-by":"crossref","unstructured":"Zhu, B. et al. Antipsychotic-induced epigenomic reorganization in frontal cortex of indivicuals with schizophrenia. Elife (2024).","DOI":"10.7554\/eLife.92393.2"},{"key":"64887_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. Gene Ontol. Consort. Nat. Genet 25, 25\u201329 (2000).","journal-title":"Gene Ontol. Consort. Nat. Genet"},{"key":"64887_CR46","unstructured":"Gene Ontology, C. et al. The Gene Ontology knowledgebase in 2023. Genetics 224 (2023)."},{"key":"64887_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/nyas.12776","volume":"1349","author":"X Zhong","year":"2015","unstructured":"Zhong, X., Drgonova, J., Li, C. Y. & Uhl, G. R. Human cell adhesion molecules: annotated functional subtypes and overrepresentation of addiction-associated genes. Ann. N. Y. Acad. Sci. 1349, 83\u201395 (2015).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"64887_CR48","first-page":"4","volume":"5","author":"TJ Gould","year":"2010","unstructured":"Gould, T. J. Addiction and cognition. Addict. Sci. Clin. Pr. 5, 4\u201314 (2010).","journal-title":"Addict. Sci. Clin. Pr."},{"key":"64887_CR49","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M. et al. KEGG: biological systems database as a model of the real world. Nucleic Acids Res 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res"},{"key":"64887_CR50","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.neuron.2015.12.019","volume":"89","author":"T Nagai","year":"2016","unstructured":"Nagai, T. et al. Phosphoproteomics of the dopamine pathway enables discovery of rap1 activation as a reward signal in vivo. Neuron 89, 550\u2013565 (2016).","journal-title":"Neuron"},{"key":"64887_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/105504901750532094","volume":"10","author":"EJ Nestler","year":"2001","unstructured":"Nestler, E. J. Molecular neurobiology of addiction. Am. J. Addict. 10, 201\u2013217 (2001).","journal-title":"Am. J. Addict."},{"key":"64887_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.0040002","volume":"4","author":"CY Li","year":"2008","unstructured":"Li, C. Y., Mao, X. & Wei, L. Genes and (common) pathways underlying drug addiction. PLoS Comput Biol. 4, e2 (2008).","journal-title":"PLoS Comput Biol."},{"key":"64887_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2024.100738","volume":"4","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. Epigenomic tomography for probing spatially defined chromatin state in the brain. Cell Rep. Methods 4, 100738 (2024).","journal-title":"Cell Rep. Methods"},{"key":"64887_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1126\/science.1179438","volume":"327","author":"I Maze","year":"2010","unstructured":"Maze, I. et al. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 327, 213\u2013216 (2010).","journal-title":"Science"},{"key":"64887_CR55","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1523\/JNEUROSCI.5638-08.2009","volume":"29","author":"HW Shen","year":"2009","unstructured":"Shen, H. W. et al. Altered dendritic spine plasticity in cocaine-withdrawn rats. J. Neurosci. 29, 2876\u20132884 (2009).","journal-title":"J. Neurosci."},{"key":"64887_CR56","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrn2699","volume":"10","author":"A Holtmaat","year":"2009","unstructured":"Holtmaat, A. & Svoboda, K. Experience-dependent structural synaptic plasticity in the mammalian brain. Nat. Rev. Neurosci. 10, 647\u2013658 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"64887_CR57","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.conb.2009.05.013","volume":"19","author":"Y Yoshihara","year":"2009","unstructured":"Yoshihara, Y., De Roo, M. & Muller, D. Dendritic spine formation and stabilization. Curr. Opin. Neurobiol. 19, 146\u2013153 (2009).","journal-title":"Curr. Opin. Neurobiol."},{"key":"64887_CR58","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1037\/pha0000253","volume":"27","author":"F Sakloth","year":"2019","unstructured":"Sakloth, F. et al. Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats. Exp. Clin. Psychopharmacol. 27, 215\u2013226 (2019).","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"64887_CR59","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.vascn.2016.07.004","volume":"82","author":"AK Goodwin","year":"2016","unstructured":"Goodwin, A. K. An intravenous self-administration procedure for assessing the reinforcing effects of hallucinogens in nonhuman primates. J. Pharm. Toxicol. Methods 82, 31\u201336 (2016).","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"64887_CR60","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1007\/s00213-019-05328-7","volume":"236","author":"A Oppong-Damoah","year":"2019","unstructured":"Oppong-Damoah, A. et al. Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice. Psychopharmacol. (Berl.) 236, 3567\u20133578 (2019).","journal-title":"Psychopharmacol. (Berl.)"},{"key":"64887_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1074633","volume":"13","author":"K Alper","year":"2022","unstructured":"Alper, K. et al. Psilocybin sex-dependently reduces alcohol consumption in C57BL\/6J mice. Front Pharm. 13, 1074633 (2022).","journal-title":"Front Pharm."},{"key":"64887_CR62","doi-asserted-by":"crossref","unstructured":"Tiwari, P. et al. Ventral hippocampal parvalbumin interneurons gate the acute anxiolytic action of the serotonergic psychedelic DOI. Neuron (2024).","DOI":"10.1016\/j.neuron.2024.08.016"},{"key":"64887_CR63","doi-asserted-by":"publisher","first-page":"112426","DOI":"10.1016\/j.drugalcdep.2024.112426","volume":"263","author":"AJ McQueney","year":"2024","unstructured":"McQueney, A. J. & Garcia, E. J. Biological sex modulates the efficacy of 2,5-dimethoxy-4-iodoamphetamine (DOI) to mitigate fentanyl demand. Drug Alcohol Depend. 263, 112426 (2024).","journal-title":"Drug Alcohol Depend."},{"key":"64887_CR64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","volume":"43","author":"MW Johnson","year":"2017","unstructured":"Johnson, M. W., Garcia-Romeu, A. & Griffiths, R. R. Long-term follow-up of psilocybin-facilitated smoking cessation. Am. J. Drug Alcohol Abus. 43, 55\u201360 (2017).","journal-title":"Am. J. Drug Alcohol Abus."},{"key":"64887_CR65","doi-asserted-by":"crossref","unstructured":"Floris, G., Dabrowski, K. R., Zanda, M. T. & Daws, S. E. Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats. Mol Psychiatry (2024).","DOI":"10.1101\/2024.05.28.596205"},{"key":"64887_CR66","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1124\/mol.108.048272","volume":"74","author":"JF Lopez-Gimenez","year":"2008","unstructured":"Lopez-Gimenez, J. F., Vilaro, M. T. & Milligan, G. Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation. Mol. Pharm. 74, 1278\u20131291 (2008).","journal-title":"Mol. Pharm."},{"key":"64887_CR67","doi-asserted-by":"crossref","unstructured":"Vohra, H. Z. et al. Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6\/SvEv mice. Psychopharmacol. (Berl), (2021).","DOI":"10.1007\/s00213-021-05913-9"},{"key":"64887_CR68","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","volume":"35","author":"GF Koob","year":"2010","unstructured":"Koob, G. F. & Volkow, N. D. Neurocircuitry of addiction. Neuropsychopharmacology 35, 217\u2013238 (2010).","journal-title":"Neuropsychopharmacology"},{"key":"64887_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.107978","volume":"167","author":"G Zanni","year":"2020","unstructured":"Zanni, G. et al. Female and male rats readily consume and prefer oxycodone to water in a chronic, continuous access, two-bottle oral voluntary paradigm. Neuropharmacology 167, 107978 (2020).","journal-title":"Neuropharmacology"},{"key":"64887_CR70","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00213-017-4536-6","volume":"234","author":"M Mavrikaki","year":"2017","unstructured":"Mavrikaki, M. et al. Oxycodone self-administration in male and female rats. Psychopharmacol. (Berl.) 234, 977\u2013987 (2017).","journal-title":"Psychopharmacol. (Berl.)"},{"key":"64887_CR71","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1111\/ejn.14152","volume":"50","author":"AK Radke","year":"2019","unstructured":"Radke, A. K. et al. Contributions of nucleus accumbens dopamine to cognitive flexibility. Eur. J. Neurosci. 50, 2023\u20132035 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"64887_CR72","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrn3119","volume":"12","author":"RZ Goldstein","year":"2011","unstructured":"Goldstein, R. Z. & Volkow, N. D. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat. Rev. Neurosci. 12, 652\u2013669 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"64887_CR73","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.1523\/JNEUROSCI.1045-08.2008","volume":"28","author":"J Peters","year":"2008","unstructured":"Peters, J., LaLumiere, R. T. & Kalivas, P. W. Infralimbic prefrontal cortex is responsible for inhibiting cocaine seeking in extinguished rats. J. Neurosci. 28, 6046\u20136053 (2008).","journal-title":"J. Neurosci."},{"key":"64887_CR74","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.brainres.2014.12.024","volume":"1628","author":"DE Moorman","year":"2015","unstructured":"Moorman, D. E., James, M. H., McGlinchey, E. M. & Aston-Jones, G. Differential roles of medial prefrontal subregions in the regulation of drug seeking. Brain Res 1628, 130\u2013146 (2015).","journal-title":"Brain Res"},{"key":"64887_CR75","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cpr.2017.10.012","volume":"66","author":"RK McHugh","year":"2018","unstructured":"McHugh, R. K., Votaw, V. R., Sugarman, D. E. & Greenfield, S. F. Sex and gender differences in substance use disorders. Clin. Psychol. Rev. 66, 12\u201323 (2018).","journal-title":"Clin. Psychol. Rev."},{"key":"64887_CR76","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1176\/appi.ajp.2011.11020289","volume":"169","author":"MN Potenza","year":"2012","unstructured":"Potenza, M. N. et al. Neural correlates of stress-induced and cue-induced drug craving: influences of sex and cocaine dependence. Am. J. Psychiatry 169, 406\u2013414 (2012).","journal-title":"Am. J. Psychiatry"},{"key":"64887_CR77","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0306-4530(03)00120-3","volume":"29","author":"AC Wihlback","year":"2004","unstructured":"Wihlback, A. C. et al. Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding. Psychoneuroendocrinology 29, 757\u2013766 (2004).","journal-title":"Psychoneuroendocrinology"},{"key":"64887_CR78","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0304-3940(01)02570-8","volume":"319","author":"V Birzniece","year":"2002","unstructured":"Birzniece, V. et al. Ovarian hormone effects on 5-hydroxytryptamine(2A) and 5-hydroxytryptamine(2C) receptor mRNA expression in the ventral hippocampus and frontal cortex of female rats. Neurosci. Lett. 319, 157\u2013161 (2002).","journal-title":"Neurosci. Lett."},{"key":"64887_CR79","doi-asserted-by":"publisher","first-page":"11202","DOI":"10.1073\/pnas.93.20.11202","volume":"93","author":"L Sklair-Tavron","year":"1996","unstructured":"Sklair-Tavron, L. et al. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl Acad. Sci. USA 93, 11202\u201311207 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64887_CR80","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.tins.2010.02.002","volume":"33","author":"SJ Russo","year":"2010","unstructured":"Russo, S. J. et al. The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci. 33, 267\u2013276 (2010).","journal-title":"Trends Neurosci."},{"key":"64887_CR81","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/jamapsychiatry.2023.1412","volume":"80","author":"L Colloca","year":"2023","unstructured":"Colloca, L., Nikayin, S. & Sanacora, G. The intricate interaction between expectations and therapeutic outcomes of psychedelic agents. JAMA Psychiatry 80, 867\u2013868 (2023).","journal-title":"JAMA Psychiatry"},{"key":"64887_CR82","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1007\/s00213-022-06221-6","volume":"239","author":"M Butler","year":"2022","unstructured":"Butler, M., Jelen, L. & Rucker, J. Expectancy in placebo-controlled trials of psychedelics: if so, so what?. Psychopharmacol. (Berl.) 239, 3047\u20133055 (2022).","journal-title":"Psychopharmacol. (Berl.)"},{"key":"64887_CR83","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s44220-023-00140-x","volume":"1","author":"TR Lii","year":"2023","unstructured":"ii, T. R. et al. Randomized trial of ketamine masked by surgical anesthesia in patients with depression. Nat. Ment. Health 1, 876\u2013886 (2023).","journal-title":"Nat. Ment. Health"},{"key":"64887_CR84","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.physbeh.2007.09.011","volume":"93","author":"FA Manno","year":"2008","unstructured":"Manno, F. A. 3rd Measurement of the digit lengths and the anogenital distance in mice. Physiol. Behav. 93, 364\u2013368 (2008).","journal-title":"Physiol. Behav."},{"key":"64887_CR85","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/mt.2008.76","volume":"16","author":"C Zincarelli","year":"2008","unstructured":"Zincarelli, C., Soltys, S., Rengo, G. & Rabinowitz, J. E. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 16, 1073\u20131080 (2008).","journal-title":"Mol. Ther."},{"key":"64887_CR86","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/nn.3181","volume":"15","author":"M Kurita","year":"2012","unstructured":"Kurita, M. et al. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat. Neurosci. 15, 1245\u20131254 (2012).","journal-title":"Nat. Neurosci."},{"key":"64887_CR87","doi-asserted-by":"publisher","first-page":"108595","DOI":"10.1016\/j.jneumeth.2020.108595","volume":"334","author":"M de la Fuente Revenga","year":"2020","unstructured":"de la Fuente Revenga, M., Vohra, H. Z. & Gonzalez-Maeso, J. Automated quantification of head-twitch response in mice via ear tag reporter coupled with biphasic detection. J. Neurosci. Methods 334, 108595 (2020).","journal-title":"J. Neurosci. Methods"},{"key":"64887_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49913-4","volume":"9","author":"M de la Fuente Revenga","year":"2019","unstructured":"de la Fuente Revenga, M. et al. Fully automated head-twitch detection system for the study of 5-HT2A receptor pharmacology in vivo. Sci. Rep. 9, 14247 (2019).","journal-title":"Sci. Rep."},{"key":"64887_CR89","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fphar.2018.00017","volume":"9","author":"T Buchborn","year":"2018","unstructured":"Buchborn, T., Lyons, T. & Knopfel, T. Tolerance and tachyphylaxis to head twitches induced by the 5-HT2A Agonist 25CN-NBOH in Mice. Front Pharm. 9, 17 (2018).","journal-title":"Front Pharm."},{"key":"64887_CR90","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1021\/acschemneuro.2c00170","volume":"13","author":"M de la Fuente Revenga","year":"2022","unstructured":"de la Fuente Revenga, M. et al. Tolerance and cross-tolerance among psychedelic and nonpsychedelic 5-HT2A receptor agonists in mice. ACS Chem. Neurosci. 13, 2436\u20132448 (2022).","journal-title":"ACS Chem. Neurosci."},{"key":"64887_CR91","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0014-2999(99)00827-4","volume":"390","author":"J Gonzalez-Maeso","year":"2000","unstructured":"Gonzalez-Maeso, J., Rodriguez-Puertas, R., Gabilondo, A. M. & Meana, J. J. Characterization of receptor-mediated [35S]GTPgammaS binding to cortical membranes from postmortem human brain. Eur. J. Pharm. 390, 25\u201336 (2000).","journal-title":"Eur. J. Pharm."},{"key":"64887_CR92","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41386-018-0143-4","volume":"44","author":"M de la Fuente Revenga","year":"2019","unstructured":"de la Fuente Revenga, M. et al. Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity. Neuropsychopharmacology 44, 443\u2013454 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"64887_CR93","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem 72, 248\u2013254 (1976).","journal-title":"Anal. Biochem"},{"key":"64887_CR94","doi-asserted-by":"publisher","first-page":"13656","DOI":"10.1073\/pnas.2232594100","volume":"100","author":"V Zachariou","year":"2003","unstructured":"Zachariou, V. et al. Essential role for RGS9 in opiate action. Proc. Natl Acad. Sci. USA 100, 13656\u201313661 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64887_CR95","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0014-2999(02)02242-2","volume":"452","author":"J Gonzalez-Maeso","year":"2002","unstructured":"Gonzalez-Maeso, J., Rodriguez-Puertas, R. & Meana, J. J. Quantitative stoichiometry of G-proteins activated by mu-opioid receptors in postmortem human brain. Eur. J. Pharm. 452, 21\u201333 (2002).","journal-title":"Eur. J. Pharm."},{"key":"64887_CR96","doi-asserted-by":"publisher","first-page":"eaar8187","DOI":"10.1126\/sciadv.aar8187","volume":"4","author":"S Ma","year":"2018","unstructured":"Ma, S., Hsieh, Y. P., Ma, J. & Lu, C. Low-input and multiplexed microfluidic assay reveals epigenomic variation across cerebellum and prefrontal cortex. Sci. Adv. 4, eaar8187 (2018).","journal-title":"Sci. Adv."},{"key":"64887_CR97","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1038\/s41596-019-0223-x","volume":"14","author":"B Zhu","year":"2019","unstructured":"Zhu, B. et al. MOWChIP-seq for low-input and multiplexed profiling of genome-wide histone modifications. Nat. Protoc. 14, 3366\u20133394 (2019).","journal-title":"Nat. Protoc."},{"key":"64887_CR98","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"64887_CR99","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"64887_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11302-9","volume":"12","author":"B Saremi","year":"2022","unstructured":"Saremi, B. et al. A comparison of strategies for generating artificial replicates in RNA-seq experiments. Sci. Rep. 12, 7170 (2022).","journal-title":"Sci. Rep."},{"key":"64887_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"64887_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24243-0","volume":"12","author":"B Hu","year":"2021","unstructured":"Hu, B. et al. Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders. Nat. Commun. 12, 3968 (2021).","journal-title":"Nat. Commun."},{"key":"64887_CR103","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.cell.2017.09.043","volume":"171","author":"B Bonev","year":"2017","unstructured":"Bonev, B. et al. Multiscale 3D genome rewiring during mouse neural development. Cell 171, 557\u2013572 e524 (2017).","journal-title":"Cell"},{"key":"64887_CR104","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","volume":"20","author":"PJ Rousseeuw","year":"1987","unstructured":"Rousseeuw, P. J. Silhouettes: A graphical aid to the interpretation and validation of cluster analysis. J. Computational Appl. Math. 20, 53\u201365 (1987).","journal-title":"J. Computational Appl. Math."},{"key":"64887_CR105","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge, S. X., Jung, D. & Yao, R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36, 2628\u20132629 (2020).","journal-title":"Bioinformatics"},{"key":"64887_CR106","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-1-0716-4051-7_6","volume":"2842","author":"PJ Hamilton","year":"2024","unstructured":"Hamilton, P. J., Lim, C. J., Nestler, E. J. & Heller, E. A. Neuroepigenetic Editing. Methods Mol. Biol. 2842, 129\u2013152 (2024).","journal-title":"Methods Mol. Biol."},{"key":"64887_CR107","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41593-019-0537-6","volume":"23","author":"WJ Wright","year":"2020","unstructured":"Wright, W. J. et al. Silent synapses dictate cocaine memory destabilization and reconsolidation. Nat. Neurosci. 23, 32\u201346 (2020).","journal-title":"Nat. Neurosci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64887-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64887-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64887-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:03:29Z","timestamp":1764029009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64887-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":107,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64887"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64887-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.G.-M. has received research support from\n                      Noetic Fund, Terran Biosciences, and Gonogo Solutions\n                      . A.M.J. had a consulting contract with\n                      Terran Biosciences\n                      . The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10206"}}